NASDAQ:PYPD

Polypid Stock Insider Trading

etoro logo Buy PYPD
*Your capital is at risk
$4.99
-0.140 (-2.73%)
At Close: Jun 23, 2026

PolyPid Stock Insider Power

Based on the 45 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 642.86K and sold 0 PYPD shares in the last 45 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 45 transactions)
100.00
Buy 642.86K shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 18, 2026
Buy
Common Stock
J-Other
Jacobovitz Yitzchak Shlomo
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Warshavsky Ori
Chief Operating Officer - Us
C-Suite Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Barenholz Yechezkel
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Akselbrad Dikla Czaczkes
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Krinsky Itzhak
Director
Director 0
Value: $0
Mar 11, 2026
Buy
Stock option (right to buy)
Story Brooke
Director
Director 17 456
Value: $70.0K
Aug 12, 2025
Buy
Stock option (right to buy)
Stein Robert Benjamin
Director
Director 14 440
Value: $38.6K
Aug 12, 2025
Buy
Stock option (right to buy)
Dror-darwish Nir
Director
Director 14 440
Value: $38.6K
Aug 12, 2025
Buy
Stock option (right to buy)
Barenholz Yechezkel
Director
Director 14 440
Value: $38.6K
Aug 12, 2025
Buy
Stock option (right to buy)
Benamram Joseph
Director
Director 14 440
Value: $38.6K
Aug 12, 2025
Buy
Stock option (right to buy)
Krinsky Itzhak
Director
Director 14 440
Value: $38.6K
Jun 09, 2025
Buy
Employee Stock option (right to buy)
Warshavsky Ori
Chief Operating Officer - Us
C-Suite Officer 25 200
Value: $67.3K
Jun 09, 2025
Buy
Employee Stock option (right to buy)
Warshavsky Ori
Chief Operating Officer - Us
C-Suite Officer 34 000
Value: $157.8K
Jun 09, 2025
Buy
Employee Stock option (right to buy)
Missulawin Jonathan
Chief Financial Officer
C-Suite Officer 28 000
Value: $74.8K
Jun 09, 2025
Buy
Employee Stock option (right to buy)
Missulawin Jonathan
Chief Financial Officer
C-Suite Officer 43 000
Value: $199.5K
Jun 09, 2025
Buy
Employee Stock option (right to buy)
Hazan Dalit Fellous
Deputy CEO, EVP, Rd, Cra
CEO / President 60 000
Value: $278.4K
Jun 09, 2025
Buy
Employee Stock option (right to buy)
Hazan Dalit Fellous
Deputy CEO, EVP, Rd, Cra
CEO / President 44 000
Value: $117.5K
Jun 09, 2025
Buy
Stock option (right to buy)
Akselbrad Dikla Czaczkes
Chief Executive Officer
CEO / President 80 000
Value: $213.6K
Jun 09, 2025
Buy
Stock option (right to buy)
Akselbrad Dikla Czaczkes
Chief Executive Officer
CEO / President 132 600
Value: $615.3K
Oct 02, 2024
Buy
Stock option (right to buy)
Stein Robert Benjamin
Director
Director 6 500
Value: $27.6K
Oct 02, 2024
Buy
Stock option (right to buy)
Dror-darwish Nir
Director
Director 6 500
Value: $27.6K
Oct 02, 2024
Buy
Stock option (right to buy)
Barenholz Yechezkel
Director
Director 6 500
Value: $27.6K
Oct 02, 2024
Buy
Stock option (right to buy)
Benamram Joseph
Director
Director 6 500
Value: $27.6K
Oct 02, 2024
Buy
Stock option (right to buy)
Krinsky Itzhak
Director
Director 6 500
Value: $27.6K
Aug 07, 2024
Buy
Employee Stock option (right to buy)
Warshavsky Ori
Chief Operating Officer - Us
C-Suite Officer 7 667
Value: $84.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT POLYPID LTD.
PolyPid
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is head...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE